NCT02082249 - An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2014

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions

Advanced Parkinson's Disease

Interventions

DRUG

ABT-SLV187

Dose levels will be individually optimized

Trial Locations (7)

Linkou Chang Gung Memorial Ho /ID# 102297, Taoyuan

National Hospital Organization Asahikawa Medical Center /ID# 101178, Asahikawa

National Hospital Organization Sagamihara National Hospital /ID# 98662, Sagamihara-shi

Osaka University Hospital /ID# 108335, Suita-shi

National Center of Neurology and Psychiatry /ID# 98664, Kodaira

Kyoto University Hospital /ID# 112136, Sakyo-ku

Seoul National University Hospital /ID# 105935, Seoul